Dexco (DXCO3.SA) Stock Price

Dexco Price

B3·CLOSED
4.66
​
Market closed

Over the last 19 years Dexco grew revenue by 18.3% annually, reaching 8.25 B BRL. Earnings per share have declined at 18.4% per year over the last 18 years. For Dexco, the net margin of 0.0% is down versus 21.1% a few years ago. At today's price the dividend yield works out to roughly 0.14%. The payout ratio is around 514% of earnings. The consensus 12-month price target for Dexco is 7.29 BRL, about 56.3% above where the stock trades today. Of 16 analysts, 13 rate the stock a buy — an overall Buy consensus.

Dexco stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dexco business model & stock analysis

Dexco SA generates revenue through its three business segments: Wood, Deca, and Ceramic Tiles. The Wood segment produces hardboard, MDP panels, MDF, HDF, and SDF panels, laminate flooring branded as Durafloor, and furniture components. The Deca segment manufactures sanitary ceramics and metal products under the Deca and Hydra brand names. The Ceramic Tiles segment offers polished porcelain tiles, special coatings, and other tiles under Ceusa and Portinari brand names. These products are sold across Brazil, Colombia, Peru, and the United States through industrial plants and commercial branches. Dexco SA's customers include furniture manufacturers, construction companies, and consumers purchasing sanitary ceramics and tiles for residential or commercial projects. The Wood division serves the furniture industry with components like MDF panels, while Deca targets bathroom and kitchen markets with its ceramic and metal products. Ceramic Tiles division caters to interior design and construction sectors with branded tile solutions. The company's revenue streams are derived from the sale of wood panels, ceramic tiles, and sanitary products. Brands such as Durafloor, Deca, Hydra, Ceusa, and Portinari drive product differentiation and customer loyalty. Sales occur through Dexco's own industrial facilities and commercial branches in multiple countries, ensuring direct market access.

Frequently asked questions about Dexco

Analysts currently set an average price target of 7.10 BRL for the Dexco stock (median: 7.29 BRL), implying +52.4 % versus the latest price. The consensus is based on 16 analyst ratings.

16 analysts currently rate the Dexco stock: 13 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Dexco to generate revenue of 8.69 B BRL and earnings per share of 0.32 BRL.

Converted at the current exchange rate, the Dexco share trades at 0.72 EUR (4.66 BRL).

The Dexco share (DXCO3.SA) is listed on 2 stock exchanges, including: B3 (São Paulo) (DXCO3.SA).

The expected revenue of Dexco is 8.69 B BRL. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Dexco is 290.73 M BRL. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Dexco is currently 14.55. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Dexco stock.

The price-to-sales ratio (P/S) of Dexco is currently 0.49. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Dexco stock.

The Eulerpool Quality Score for Dexco is 2/10.

The ISIN of Dexco is BRDXCOACNOR8. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Dexco is DXCO3.SA. The ticker symbol is used to trade Dexco shares on the stock exchange.

Fair ValueTerminal
4.61 BRL
Over-/UndervaluationTerminal
Fairly valued
Industry
Paper & Forest Products
Number of shares
Employees
Revenue per Employee
579,754.85 BRL
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website dex.co
Country
Brazil
Currency
BRL
Initial public offering
Sep 10, 2007
ISIN
BRDXCOACNOR8
Cusip
P3R899102
Market capitalization
3.82 B BRLMid Cap
52-Week Range
PEG
143.43
P/E ratio
P/Ee 2026
13.15
P/Ee 2027
7.40
P/Ee 2028
6.74
P/S
P/Se
0.49
EV/EBIT
64.18
P/B Ratio
0.56
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.01 %
Dividend
Dividend yield
0.14 %
Est. Dividend Yield
35.02 %
Payout Ratio
514.49 %
Dividend growth Ø5Y
124.59 %
Dividend payments per year
2
Dividend paid since
9 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Nov 21, 2026, 3:35 AM

Dexco Peer Group

Dexco Ticker

B3 · DXCO3.SAB3 · DXCO3.SA

Dexco FIGI

DXCO3:BZ · BBG000QBDM58DXCO3:BS · BBG000QBDMT2DXCO3:BN · BBG000QBDP42

All fundamentals and in-depth analysis of Dexco

Our stock analysis for Dexco stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dexco. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.